Current:Home > MyAnother first for JPMorgan CEO Jamie Dimon, selling shares of the bank he’s run for nearly 2 decades -PureWealth Academy
Another first for JPMorgan CEO Jamie Dimon, selling shares of the bank he’s run for nearly 2 decades
View
Date:2025-04-20 16:11:07
Jamie Dimon will do something he has never done before in nearly two decades as the head of JPMorgan Chase & Co. - sell shares in the company.
The top executive of the nation’s largest bank will sell 1 million shares starting next year, according to a regulatory filing this week.
JPMorgan sought to reassure investors that the stock sale is not a matter of concern.
“Mr. Dimon continues to believe the company’s prospects are very strong and his stake in the company will remain very significant,” the filing said.
Dimon and his family currently hold about 8.6 million shares of the bank.
And JPMorgan has become a titan under Dimon’s leadership.
Dimon became CEO of JPMorgan in January 2006 and added on the chairman role a year later. The value of the bank, with $3.2 trillion in assets, has tripled during Dimon’s tenure, and it now as a market capitalization of more than $409.1 billion, according to FactSet.
The value of JPMorgan’s shares have also tripled in that time and they are up another 10% in the past year.
The New York bank reported a 35% surge in profits during its most recent quarter, fueled by a rapid rise in interest rates.
Dimon has also come to be considered a powerful and frank voice on Wall Street. He issued a sobering statement about the current state of world affairs and economic instability.
When the bank posted another blockbuster earnings report two weeks ago, Dimon warned, “This may be the most dangerous time the world has seen in decades.”
Dimon laid out a laundry list of major issues: the Russia-Ukraine War, the new war between Israel and the Palestinians in Gaza, high levels of government debt and deficits, high inflation, as well as the tight labor market, where worker demands for increased wages have led to high-profile strikes in manufacturing and entertainment.
Shares of JPMorgan Chase & Co. declined more than 2% Friday.
veryGood! (35529)
Related
- How to watch the 'Blue Bloods' Season 14 finale: Final episode premiere date, cast
- Big Pokey, pioneering Houston rapper, dies at 48
- Mormon crickets plague parts of Nevada and Idaho: It just makes your skin crawl
- Ireland is paying up to $92,000 to people who buy homes on remote islands. Here's how it works.
- A South Texas lawmaker’s 15
- Building a better brain through music, dance and poetry
- Some Young Republicans Embrace a Slower, Gentler Brand of Climate Activism
- Robert De Niro and Girlfriend Tiffany Chen Step Out at Cannes Film Festival After Welcoming Baby
- New data highlights 'achievement gap' for students in the US
- 'Oppenheimer' sex scene with Cillian Murphy sparks backlash in India: 'Attack on Hinduism'
Ranking
- Trump wants to turn the clock on daylight saving time
- Biden Names Ocasio-Cortez, Kerry to Lead His Climate Task Force, Bridging Democrats’ Divide
- Documents in abortion pill lawsuit raise questions about ex-husband's claims
- Global Warming Is Changing the Winds Off Antarctica, Driving Ice Melt
- Whoopi Goldberg is delightfully vile as Miss Hannigan in ‘Annie’ stage return
- Bill Barr condemns alleged Trump conduct, but says I don't like the idea of a former president serving time
- Transcript: Former Attorney General William Barr on Face the Nation, June 18, 2023
- With 10 Appointees on the Ninth Circuit, Trump Seeks to Tame His Nemesis
Recommendation
New Zealand official reverses visa refusal for US conservative influencer Candace Owens
This Week in Clean Economy: Pressure Is on Obama to Finalize National Solar Plan
Q&A: Plug-In Leader Discusses Ups and Downs of America’s E.V. Transformation
Strep is bad right now — and an antibiotic shortage is making it worse
Federal Spending Freeze Could Have Widespread Impact on Environment, Emergency Management
Global Warming Is Pushing Pacific Salmon to the Brink, Federal Scientists Warn
How an abortion pill ruling could threaten the FDA's regulatory authority
Arctic National Wildlife Refuge Faces New Drilling Risk from Congress